암 진단용 AI 시장 : 시장 분석 및 예측 - 유형별, 제품별, 서비스별, 기술별, 컴퍼넌트별, 용도별, 전개 모드별, 최종 사용자별, 모듈별, 기능별(-2035년)

AI In Cancer Diagnostics Market is anticipated to expand from $268.1 million in 2024 to $2,360.1 million by 2034, growing at a CAGR of approximately 24.3%. The AI in Cancer Diagnostics Market encompasses technologies utilizing artificial intelligence to enhance the accuracy and efficiency of cancer detection and diagnosis. This market integrates machine learning algorithms, image recognition, and predictive analytics to aid pathologists and radiologists. As demand for early cancer detection rises, AI-driven solutions are pivotal in reducing diagnostic errors and improving patient outcomes. The market is poised for growth, driven by advancements in AI technology, increasing healthcare investments, and a growing emphasis on personalized medicine.

The AI in Cancer Diagnostics Market is poised for significant growth, driven by advancements in machine learning and imaging technologies. The imaging segment is the top-performing sub-segment, with AI-powered imaging tools enhancing early detection and diagnostic accuracy. Within this segment, radiology and pathology AI applications are leading, leveraging deep learning to improve diagnostic precision. The second highest performing sub-segment is the genomics segment, where AI is revolutionizing personalized medicine by analyzing complex genetic data. AI-driven genomic tools are crucial in identifying cancer biomarkers and tailoring treatment plans. The integration of AI in biopsy analysis is also gaining momentum, offering enhanced insights into tumor characteristics. Moreover, AI algorithms for predictive analytics are becoming indispensable, aiding in prognosis and treatment outcome predictions. The adoption of AI in cancer diagnostics is further propelled by collaborations between tech companies and healthcare providers, fostering innovation. Enhanced regulatory frameworks and increasing awareness of AI's potential are expected to drive future market expansion.

Market Snapshot:

The AI in Cancer Diagnostics Market is witnessing a dynamic shift in market share. Pricing strategies are increasingly competitive, driven by technological advancements and the introduction of innovative diagnostic solutions. Recent product launches have demonstrated a focus on enhancing accuracy and reducing diagnostic time. Companies are leveraging AI to improve patient outcomes and streamline processes, which is fostering rapid adoption across healthcare institutions globally. This evolution is setting the stage for a transformative impact on cancer diagnostics. Competition in the AI in Cancer Diagnostics Market is intensifying, with key players like IBM Watson Health and Google Health leading the charge. These companies are investing heavily in research and development to maintain a competitive edge. Regulatory influences, particularly in North America and Europe, are crucial in shaping market dynamics. Compliance with stringent standards ensures product efficacy and safety, thereby boosting consumer trust. The market is poised for growth, driven by technological innovations and favorable regulatory environments.

Geographical Overview:

The AI in cancer diagnostics market is poised for substantial growth across diverse regions. North America leads the charge, propelled by its advanced healthcare infrastructure and robust AI research initiatives. The region's focus on early cancer detection and personalized medicine further augments this growth. Europe follows closely, with significant investments in AI-driven healthcare solutions. The continent's emphasis on regulatory frameworks ensures the safe integration of AI technologies in diagnostics. Asia Pacific is emerging as a vital growth pocket, driven by increasing cancer prevalence and technological advancements. Countries like China and India are at the forefront, investing heavily in AI research and healthcare innovation. These nations are poised to revolutionize cancer diagnostics with their rapid adoption of AI technologies. Meanwhile, Latin America and the Middle East & Africa are gradually recognizing the potential of AI in healthcare. These regions are beginning to invest in AI infrastructure, promising future growth in cancer diagnostics.

Key Trends and Drivers:

The AI in Cancer Diagnostics Market is experiencing robust growth due to technological advancements and increasing cancer prevalence. Key trends include the integration of AI with imaging technologies, enhancing the accuracy and speed of cancer detection. Machine learning algorithms are being developed to analyze complex datasets, improving diagnostic precision and personalized treatment planning. The demand for early and accurate cancer diagnosis is driving the adoption of AI solutions. Healthcare providers are increasingly leveraging AI to reduce diagnostic errors and improve patient outcomes. The growing availability of large datasets is enabling the training of more sophisticated AI models, further propelling market growth. Additionally, collaborations between technology companies and healthcare institutions are fostering innovation in AI applications for cancer diagnostics. Opportunities are emerging in developing regions where healthcare infrastructure is expanding. Companies that offer scalable and cost-effective AI solutions are well-positioned to capture market share. Furthermore, regulatory support for AI-driven diagnostic tools is enhancing their adoption, promising sustained market expansion.

Restraints and Challenges:

The AI in Cancer Diagnostics Market is confronted with several significant restraints and challenges. Foremost among these is the regulatory compliance and approval process, which remains stringent and time-consuming, often delaying market entry and innovation. Additionally, the integration of AI systems into existing healthcare infrastructure presents technical and operational difficulties, requiring substantial investment and training. Data privacy and security concerns also pose critical challenges, as sensitive patient information must be safeguarded against breaches and misuse. Furthermore, there is a notable scarcity of high-quality, annotated datasets necessary for training AI algorithms, which limits the efficacy and accuracy of diagnostic tools. Lastly, the market faces resistance from healthcare professionals who may be skeptical of AI's reliability and fear potential job displacement. These challenges collectively impede the rapid adoption and growth of AI technologies in cancer diagnostics, necessitating strategic solutions to overcome them.

Key Players:

Tempus, PathAI, Zebra Medical Vision, Freenome, CureMetrix, Ibex Medical Analytics, Deep Lens, Proscia, Oncora Medical, Enlitic, Owkin, Miramus, Lunit, Qure.ai, Aiforia, Kheiron Medical, Huron Digital Pathology, Viz.ai, Koios Medical, Aidence

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by Deployment
• 2.8 Key Market Highlights by End User
• 2.9 Key Market Highlights by Module
• 2.10 Key Market Highlights by Functionality

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Imaging
  • 4.1.2 Genomics
  • 4.1.3 Pathology
  • 4.1.4 Radiology
  • 4.1.5 Biomarker Analysis
  • 4.1.6 Clinical Decision Support
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Software
  • 4.2.2 Hardware
  • 4.2.3 AI Platforms
  • 4.2.4 Diagnostic Devices
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Consulting Services
  • 4.3.2 Integration Services
  • 4.3.3 Maintenance Services
  • 4.3.4 Training and Support
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Machine Learning
  • 4.4.2 Deep Learning
  • 4.4.3 Natural Language Processing
  • 4.4.4 Computer Vision
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 AI Algorithms
  • 4.5.2 Data Management
  • 4.5.3 User Interface
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Breast Cancer
  • 4.6.2 Lung Cancer
  • 4.6.3 Prostate Cancer
  • 4.6.4 Colorectal Cancer
• 4.7 Market Size & Forecast by Deployment (2020-2035)
  • 4.7.1 Cloud-Based
  • 4.7.2 On-Premises
  • 4.7.3 Hybrid
• 4.8 Market Size & Forecast by End User (2020-2035)
  • 4.8.1 Hospitals
  • 4.8.2 Diagnostic Laboratories
  • 4.8.3 Research Institutes
• 4.9 Market Size & Forecast by Module (2020-2035)
  • 4.9.1 Data Analysis
  • 4.9.2 Predictive Modelling
  • 4.9.3 Risk Assessment
• 4.10 Market Size & Forecast by Functionality (2020-2035)
  • 4.10.1 Detection
  • 4.10.2 Prognosis
  • 4.10.3 Treatment Planning

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 Deployment
    • 5.2.1.8 End User
    • 5.2.1.9 Module
    • 5.2.1.10 Functionality
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 Deployment
    • 5.2.2.8 End User
    • 5.2.2.9 Module
    • 5.2.2.10 Functionality
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 Deployment
    • 5.2.3.8 End User
    • 5.2.3.9 Module
    • 5.2.3.10 Functionality
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 Deployment
    • 5.3.1.8 End User
    • 5.3.1.9 Module
    • 5.3.1.10 Functionality
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 Deployment
    • 5.3.2.8 End User
    • 5.3.2.9 Module
    • 5.3.2.10 Functionality
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 Deployment
    • 5.3.3.8 End User
    • 5.3.3.9 Module
    • 5.3.3.10 Functionality
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 Deployment
    • 5.4.1.8 End User
    • 5.4.1.9 Module
    • 5.4.1.10 Functionality
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 Deployment
    • 5.4.2.8 End User
    • 5.4.2.9 Module
    • 5.4.2.10 Functionality
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 Deployment
    • 5.4.3.8 End User
    • 5.4.3.9 Module
    • 5.4.3.10 Functionality
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 Deployment
    • 5.4.4.8 End User
    • 5.4.4.9 Module
    • 5.4.4.10 Functionality
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 Deployment
    • 5.4.5.8 End User
    • 5.4.5.9 Module
    • 5.4.5.10 Functionality
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 Deployment
    • 5.4.6.8 End User
    • 5.4.6.9 Module
    • 5.4.6.10 Functionality
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 Deployment
    • 5.4.7.8 End User
    • 5.4.7.9 Module
    • 5.4.7.10 Functionality
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 Deployment
    • 5.5.1.8 End User
    • 5.5.1.9 Module
    • 5.5.1.10 Functionality
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 Deployment
    • 5.5.2.8 End User
    • 5.5.2.9 Module
    • 5.5.2.10 Functionality
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 Deployment
    • 5.5.3.8 End User
    • 5.5.3.9 Module
    • 5.5.3.10 Functionality
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 Deployment
    • 5.5.4.8 End User
    • 5.5.4.9 Module
    • 5.5.4.10 Functionality
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 Deployment
    • 5.5.5.8 End User
    • 5.5.5.9 Module
    • 5.5.5.10 Functionality
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 Deployment
    • 5.5.6.8 End User
    • 5.5.6.9 Module
    • 5.5.6.10 Functionality
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 Deployment
    • 5.6.1.8 End User
    • 5.6.1.9 Module
    • 5.6.1.10 Functionality
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 Deployment
    • 5.6.2.8 End User
    • 5.6.2.9 Module
    • 5.6.2.10 Functionality
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 Deployment
    • 5.6.3.8 End User
    • 5.6.3.9 Module
    • 5.6.3.10 Functionality
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 Deployment
    • 5.6.4.8 End User
    • 5.6.4.9 Module
    • 5.6.4.10 Functionality
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 Deployment
    • 5.6.5.8 End User
    • 5.6.5.9 Module
    • 5.6.5.10 Functionality

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Tempus
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 PathAI
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Zebra Medical Vision
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Freenome
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 CureMetrix
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Ibex Medical Analytics
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Deep Lens
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Proscia
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Oncora Medical
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Enlitic
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Owkin
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Miramus
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Lunit
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Qure.ai
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Aiforia
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Kheiron Medical
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Huron Digital Pathology
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Viz.ai
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Koios Medical
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Aidence
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us